This question has been recently addressed by Kim et al. (2020), who found that the anticolitic effects of this indoleamine require Toll-like receptor 4 (TLR4) signalling, since it alleviated induced colitis and reverted microbial dysbiosis only in wild-type but not in TLR4 knockout mice. This evidence concerns the gene TLR4 and colitis.